📰 Convertible Notes News
Page 33 - Convertible Notes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Convertible Notes. Real-time updates on events, politics, business and more.
February 16, 2023
Fiscal year diluted EPS of $1.70 and adjusted diluted EPS of $2.31 Fiscal year net income margin of 2.5% and adjusted EBITDA margin of 6.4% Fiscal year revenue of $3.3 billion; 2023 fiscal year... | February 16, 2023
February 16, 2023
/PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced financial guidance...
February 16, 2023
Reiterates Fiscal Year 2023 Guidance; Provides Comparative Fiscal Year 2023 Financials Aligned to Continuing Operations FORT WORTH, Texas, Feb. 16, 2023 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and c...
February 15, 2023
Yandex N.V. / Key word(s): Quarter Results/Quarter Results Yandex Announces Fourth Quarter and Full-Year 2022 Financial Results 15.02.2023 / 13:00 MSK The issuer is solely responsible for
February 15, 2023
Yandex N.V. / Key word(s): Quarter Results/Quarter Results Yandex Announces Fourth Quarter and Full-Year 2022 Financial Results 15.02.2023 / 13:00 MSK The issuer is solely responsible for the content of this announcement. Yandex Announces Fourth Quarter and Full-Year 2022 Financial Results MOS...
February 15, 2023
Investegate announcements from Mineral & Financial, Investment Update: Golden Sun Resources Ltd
February 10, 2023
Valoe Corporation Inside Information 10 February 2023 at 17.40 VALOE HAS AGREED ON A EUR 5,000,000 FINANCIAL ARRANGEMENT WITH WINANCE. THE FUNDING... | February 10, 2023
February 9, 2023
Strong full year performance driven by high value recurring revenues Fourth quarter and full year operating highlights: Three months ended Twelve months ended December 31 December 31(in millions of US$
February 8, 2023
Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, Chi...
February 3, 2023
~ Strategic transaction to meaningfully reduce interest expense ~~ Immediately earnings accretive in 2023 ~ PLANO, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE)...